Tadashi Manabe

2.0k total citations
12 papers, 216 citations indexed

About

Tadashi Manabe is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tadashi Manabe has authored 12 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Tadashi Manabe's work include Lung Cancer Treatments and Mutations (7 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (2 papers). Tadashi Manabe is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (2 papers). Tadashi Manabe collaborates with scholars based in Japan and United States. Tadashi Manabe's co-authors include Yutaka Kato, Hidenori Mochizuki, Yukiko Tanaka, Ichiro Kawada, Hiroyuki Yasuda, Keita Masuzawa, Kenzo Soejima, Keigo Kobayashi, Shinnosuke Ikemura and Junko Hamamoto and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Tadashi Manabe

12 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadashi Manabe Japan 6 101 95 90 54 35 12 216
Félicie Sherer Belgium 6 54 0.5× 71 0.7× 90 1.0× 46 0.9× 20 0.6× 7 231
Sook Kyung South Korea 8 104 1.0× 65 0.7× 105 1.2× 35 0.6× 34 1.0× 29 229
Bijesh George India 7 74 0.7× 28 0.3× 131 1.5× 32 0.6× 13 0.4× 11 223
Jasmine Sukumar United States 7 117 1.2× 43 0.5× 77 0.9× 30 0.6× 8 0.2× 20 238
Priya Chudasama Germany 6 68 0.7× 49 0.5× 73 0.8× 32 0.6× 37 1.1× 11 168
Katrin Madjar Germany 7 77 0.8× 52 0.5× 97 1.1× 40 0.7× 8 0.2× 14 187
Jordan Shafran United States 7 67 0.7× 47 0.5× 204 2.3× 49 0.9× 20 0.6× 10 264
Kyoung‐Joo Jenny Park United States 7 85 0.8× 51 0.5× 59 0.7× 24 0.4× 11 0.3× 7 179
Teresa Laguna Spain 9 86 0.9× 41 0.4× 106 1.2× 51 0.9× 8 0.2× 11 254
Stephanie The United States 7 74 0.7× 44 0.5× 71 0.8× 63 1.2× 22 0.6× 15 219

Countries citing papers authored by Tadashi Manabe

Since Specialization
Citations

This map shows the geographic impact of Tadashi Manabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Manabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Manabe more than expected).

Fields of papers citing papers by Tadashi Manabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Manabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Manabe. The network helps show where Tadashi Manabe may publish in the future.

Co-authorship network of co-authors of Tadashi Manabe

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Manabe. A scholar is included among the top collaborators of Tadashi Manabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Manabe. Tadashi Manabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Terai, Hideki, Junko Hamamoto, Katsura Emoto, et al.. (2020). SHOC2 Is a Critical Modulator of Sensitivity to EGFR–TKIs in Non–Small Cell Lung Cancer Cells. Molecular Cancer Research. 19(2). 317–328. 13 indexed citations
2.
Manabe, Tadashi, Hiroyuki Yasuda, Hideki Terai, et al.. (2020). IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer. Molecular Cancer Research. 18(4). 549–559. 39 indexed citations
3.
Kobayashi, Keigo, Hideki Terai, Hiroyuki Yasuda, et al.. (2020). Functional dissection of the KRAS G12C mutation by comparison among multiple oncogenic driver mutations in a lung cancer cell line model. Biochemical and Biophysical Research Communications. 534. 1–7. 1 indexed citations
4.
Terai, Hideki, Junko Hamamoto, Tadashi Manabe, et al.. (2020). Abstract 3081: SHOC2 is a critical modulator of the sensitivity to EGFR-TKI in non-small cell lung cancer cells. Cancer Research. 80(16_Supplement). 3081–3081. 1 indexed citations
5.
Kakimi, Kazuhiro, Hirokazu Matsushita, Keita Masuzawa, et al.. (2020). Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study. Journal for ImmunoTherapy of Cancer. 8(2). e001185–e001185. 30 indexed citations
6.
Yasuda, Hiroyuki, Keigo Kobayashi, Tetsuo Tani, et al.. (2019). Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with Cetuximab. Molecular Cancer Therapeutics. 18(9). 1593–1601. 3 indexed citations
7.
Kobayashi, Keigo, Katsuhiko Naoki, Tadashi Manabe, et al.. (2018). Comparison of detection methods of <em>EGFR</em> T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer. OncoTargets and Therapy. Volume 11. 3335–3343. 20 indexed citations
8.
Yasuda, Hiroyuki, Junko Hamamoto, Keita Masuzawa, et al.. (2018). Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations. Lung Cancer. 127. 146–152. 40 indexed citations
9.
Miyazaki, Yutaka, et al.. (2006). Synthesis and evaluation of 4-substituted benzylamine derivatives as β-tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(11). 2986–2990. 4 indexed citations
10.
Kato, Yutaka, Tadashi Manabe, Yukiko Tanaka, & Hidenori Mochizuki. (1999). Effect of an Orally Active Th1/Th2 Balance Modulator, M50367, on IgE Production, Eosinophilia, and Airway Hyperresponsiveness in Mice. The Journal of Immunology. 162(12). 7470–7479. 61 indexed citations
11.
Ueda, Yasuyuki, et al.. (1997). Determination of Formulation Quantities for Three Kinds of Antacid Using Triangle Coordinates. YAKUGAKU ZASSHI. 117(3). 185–192. 2 indexed citations
12.
Nakajima, Masamitsu, et al.. (1992). Appearance of mesothelioma cells in sputum. A case report.. PubMed. 36(5). 731–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Félicie Sherer Breakdown of academic impact, for papers by Sook Kyung Breakdown of academic impact, for papers by Bijesh George Breakdown of academic impact, for papers by Jasmine Sukumar Breakdown of academic impact, for papers by Priya Chudasama Breakdown of academic impact, for papers by Katrin Madjar Breakdown of academic impact, for papers by Jordan Shafran Breakdown of academic impact, for papers by Kyoung‐Joo Jenny Park Breakdown of academic impact, for papers by Teresa Laguna Breakdown of academic impact, for papers by Stephanie The
Rankless by CCL
2026